Literature DB >> 12687695

Long-term effects of decreased noradrenergic central nervous system innervation on pain behavior and opioid antinociception.

Luc Jasmin1, Abdennacer Boudah, Peter T Ohara.   

Abstract

Here we examine whether a permanent reduction in the noradrenergic (NA) innervation of the spinal cord leads to a chronic decreased nociceptive threshold. NA denervation of rats was achieved by intrathecal injection of dopamine beta-hydroxylase antibodies conjugated to the toxin saporin. A subset of animals also underwent unilateral L5 spinal nerve ligature to induce sustained neuropathic pain behavior. NA fibers and terminals were lost throughout the spinal cord 2 weeks after toxin application and were still absent 12 months later, indicating that regeneration did not occur. There was also a widespread loss of NA terminals in the cerebral cortex, whereas innervation of the hypothalamus and amygdala were close to normal and NA innervation of the brainstem was moderately reduced. There was extensive loss of NA cells in the locus coeruleus and A5 and A7 cell groups. Dopaminergic and serotoninergic innervation was normal. Intracerebroventricular injection of the toxin resulted in additional NA reduction in the hypothalamus, amygdala, and A1 and A2 cell groups. Long-term removal of NA afferents did not affect nociceptive thresholds. Neuropathic animals showed greater mechanical hyperalgesia in the affected hindpaw only during the first 60 days after toxin. Rats lacking NA spinal afferents were less responsive to the antinociceptive effects of morphine, especially in the neuropathic hindpaw, and did not display opioid-dependent stress analgesia. Finally, in the spinal cord of toxin-treated rats, immunoreactivity for substance P was decreased, whereas that of its receptor (NK1) was increased. These animals exhibited antinociception to a low dose of an NK1 receptor antagonist. Our results suggest that NA contributes only modestly to determining the nociceptive threshold and that its antinociceptive effects are closely linked to opioidergic and tachykinergic neurotransmission. Copyright 2003 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12687695     DOI: 10.1002/cne.10633

Source DB:  PubMed          Journal:  J Comp Neurol        ISSN: 0021-9967            Impact factor:   3.215


  27 in total

1.  Effect of lesion of a5 and a7 brainstem noradrenergic areas or transection of brainstem pathways on sympathoadrenal activity in rats during immobilization stress.

Authors:  Richard Kvetnansky; Ibolya Bodnar; Tal Shahar; Gabriela Uhereczky; Olga Krizanova; Boris Mravec
Journal:  Neurochem Res       Date:  2006-03-29       Impact factor: 3.996

Review 2.  Conditioned pain modulation: a predictor for development and treatment of neuropathic pain.

Authors:  Yelena Granovsky
Journal:  Curr Pain Headache Rep       Date:  2013-09

3.  Prophylactic treatment with the tricyclic antidepressant desipramine prevents development of paclitaxel-induced neuropathic pain through activation of endogenous analgesic systems.

Authors:  Liting Deng; Wan-Hung Lee; Zhili Xu; Alexandros Makriyannis; Andrea G Hohmann
Journal:  Pharmacol Res       Date:  2016-10-20       Impact factor: 7.658

4.  High prevalence of restless legs syndrome in somatoform pain disorder.

Authors:  Martin Aigner; Wolfgang Prause; Marion Freidl; Maria Weiss; Shahriar Izadi; Michael Bach; Bernd Saletu
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2007-02       Impact factor: 5.270

5.  The Neurotoxin DSP-4 Induces Hyperalgesia in Rats that is Accompanied by Spinal Oxidative Stress and Cytokine Production.

Authors:  Jillienne C Touchette; Joshua W Little; Gerald H Wilken; Daniela Salvemini; Heather Macarthur
Journal:  Neuroscience       Date:  2018-02-05       Impact factor: 3.590

Review 6.  The noradrenergic locus coeruleus as a chronic pain generator.

Authors:  Bradley K Taylor; Karin N Westlund
Journal:  J Neurosci Res       Date:  2016-09-29       Impact factor: 4.164

7.  The human amygdala and pain: evidence from neuroimaging.

Authors:  Laura E Simons; Eric A Moulton; Clas Linnman; Elizabeth Carpino; Lino Becerra; David Borsook
Journal:  Hum Brain Mapp       Date:  2012-10-25       Impact factor: 5.038

8.  GABA-A receptor activity in the noradrenergic locus coeruleus drives trigeminal neuropathic pain in the rat; contribution of NAα1 receptors in the medial prefrontal cortex.

Authors:  R Kaushal; B K Taylor; A B Jamal; L Zhang; F Ma; R Donahue; K N Westlund
Journal:  Neuroscience       Date:  2016-08-09       Impact factor: 3.590

9.  Dual allosteric modulation of opioid antinociceptive potency by α2A-adrenoceptors.

Authors:  Anne-Julie Chabot-Doré; Magali Millecamps; Lina Naso; Dominic Devost; Phan Trieu; Marjo Piltonen; Luda Diatchenko; Carolyn A Fairbanks; George L Wilcox; Terence E Hébert; Laura S Stone
Journal:  Neuropharmacology       Date:  2015-08-06       Impact factor: 5.250

10.  Retrograde adenoviral vector targeting of nociresponsive pontospinal noradrenergic neurons in the rat in vivo.

Authors:  Patrick W Howorth; Anja G Teschemacher; Anthony E Pickering
Journal:  J Comp Neurol       Date:  2009-01-10       Impact factor: 3.215

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.